GlassScriptPhysician profile
Vikram Bisen
NPI 1568625523
$10,879.41
in general payments reported to CMS, 2019-2025
35 companies · $1,040 in 2025
The $1,040 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,749 · 2020: $2,661 · 2021: $1,024 · 2022: $818 · 2023: $2,491 · 2024: $1,096 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,534 · Travel and Lodging: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,534.27 |
| Travel and Lodging | $1,092.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,141.26 | 2019-2020 | |
| Medtronic, INC. | $1,955.77 | 2021-2025 | Venaseal, Corevalve Evolut R, V-Loc 180 |
| Boston Scientific Corporation | $1,395.96 | 2019-2025 | Sentinel, Varithena Administration Pack, Watchman Flx |
| Inari Medical, INC. | $984.40 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $438.80 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $436.08 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $322.92 | 2019-2025 | |
| Pfizer INC. | $317.87 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $304.20 | 2023-2024 | Venclose Maven Catheter, True Dilatation |
| Abiomed | $278.48 | 2020-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $270.96 | 2019-2025 | Farxiga, Wainua |
| Shockwave Medical, INC | $264.78 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.42 | 2019-2025 | Lifevest |
| Amgen INC. | $200.75 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $167.28 | 2023-2025 | Synergy Ablation System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $120.62 | 2019-2022 | |
| Amarin Pharma, INC. | $120.35 | 2019-2021 | |
| Novo Nordisk INC | $111.08 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $96.10 | 2023-2025 | Verquvo, Winrevair |
| Insmed, INC. | $85.85 | 2020 | |
| Chiesi USA, INC. | $73.14 | 2023-2025 | Kengreal, Cleviprex |
| Edwards Lifesciences Corporation | $67.81 | 2020-2025 | Sapien 3 Ultra Resilia |
| Angiodynamics, INC. | $67.34 | 2023-2025 | Alphavac |
| Terumo Medical Corporation | $62.50 | 2021 | |
| Stryker Corporation | $53.00 | 2025 | Artix Mt |
| Teleflex LLC | $49.46 | 2023-2025 | Manta, Guideliner |
| Cardinal Health 200 LLC | $47.75 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.00 | 2023-2025 | Jardiance |
| Abbott Laboratories | $38.72 | 2022 | |
| Esperion Therapeutics, INC. | $34.80 | 2021-2025 | Nexletol |
| Ge Healthcare | $33.00 | 2025 | |
| Sanofi-Aventis U.S. LLC | $29.76 | 2022-2023 | |
| Siemens Medical Solutions USA, INC. | $16.39 | 2025 | Symbia_evo |
| Asahi Intecc USA, INC. | $12.50 | 2021 | |
| Cardiovascular Systems INC. | $7.31 | 2023 | Diamondback Coronary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Bisen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.